Clinical Trial Update: Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

View source ↗

Summary

This Mayo Clinic-led trial evaluates molecular analysis of suspected or high-risk lung cancer to drive individualized care. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Status: RECRUITING